Old Articles: <Older 8691-8700 Newer> |
|
Chemistry World October 1, 2013 Emma Stoye |
Japan confirms Novartis clinical trial data fabrication Japan's ministry of health has concluded that studies based on clinical trials for Novartis's blood pressure drug Diovan contain manipulated data. It is now investigating whether the company has broken Japanese law by citing these studies to promote the product. |
CIO September 27, 2013 |
How IT Can Produce Better Patient Care For Dr. Bob Laskowski, president and CEO of Christiana Care Health System, technology means empowering physicians and patients. |
CIO September 26, 2013 Stephanie Overby |
Big Data Project Cuts Prescription Costs Express Scripts analytics portal helps doctors prescribe more cost-effective medicines. |
Chemistry World September 25, 2013 Phillip Broadwith |
New respiratory drugs neck and neck A flurry of regulatory approvals has seen three new drugs approved for asthma and chronic obstructive pulmonary disease in the European and Japanese markets. |
Chemistry World September 25, 2013 Phillip Broadwith |
Nanobody inflammation drug attracts Abbvie Belgian biotech firm Ablynx has agreed a global licensing deal with Abbvie for its nanobody drug candidate ALX-0061. |
Chemistry World September 18, 2013 Phillip Broadwith |
Service with a smile Contract organic synthesis is a competitive business. Service companies in China and India offer their skills at prices it can be difficult for western firms to compete with. So how does a company stand out from the crowd? |
Chemistry World September 17, 2013 Ian Randall |
Synthetic drug found in nature The bark of Nauclea latifolia contains tramadol at medicinal concentrations. |
Chemistry World September 17, 2013 Phillip Broadwith |
GSK criticized for trial data secrecy An Italian research institute has withdrawn from a public -- private partnership after quarrelling with GlaxoSmithKline about access to data from an antibiotic clinical trial being run by the institute. |
Pharmaceutical Executive September 1, 2013 Arthur Lazarus |
Promotional Review Committees: How to Achieve High Performing Teams What it takes for promotional review teams to function at their best and avoid costly mistakes. |
Pharmaceutical Executive September 1, 2013 Shantanu Agrawal |
Making Sense of the Sunshine Act: A New Era for Drug Promotion Now that the Sunshine Act's Open Payments spending disclosure program is live, the federal government's lead officer for compliance explains how the new web-based system will work and how US industry, providers, and patients will be better off by making their relationships fully transparent. |
<Older 8691-8700 Newer> Return to current articles. |